11.11.2019 • News

Trinseo Retains Stade PC Plant

Trinseo Retains Stade PC Plant (c) Trinseo
Trinseo Retains Stade PC Plant (c) Trinseo

Following a strategic review of its polycarbonate (PC) activities announced in May this year, US plastics and rubber producer Trinseo has decided to keep its PC manufacturing plant in Stade, Germany.

At the time, president and CEO Frank Bozich said the review had been spurred by significantly declining margins resulting from low demand as well as new capacity in China. Trinseo consumes about 40% of the Stade plant’s 145,000 t/y output and sells the rest on the merchant market.

Speaking to analysts during the company’s Q3 earnings call, Bozich said the decision to keep the plant was driven by the economics of supplying PC to its higher-margin downstream compounding business.

At the same time, Trinseo has identified structural and raw material cost savings that should provide a more sustainable outlook, and now intends to operate the site for the “foreseeable future,” Bozich added that the company will continue looking at its assets with a view to optimising its portfolio.

Separately, Trinseo plans to build a pilot facility for thermoplastic elastomers (TPEs) in Hsinchu, Taiwan, supplying customers in the automotive, consumer electronics, footwear and medical markets. Start-up is anticipated in 2020.  The investment is the next step in the company’s TPE growth roadmap following the acquisition of Italy’s API in July 2017.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.